Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Accumulated Expenses (2020 - 2025)

GoHealth's Accumulated Expenses history spans 6 years, with the latest figure at $60.9 million for Q3 2025.

  • For Q3 2025, Accumulated Expenses rose 23.12% year-over-year to $60.9 million; the TTM value through Sep 2025 reached $60.9 million, up 23.12%, while the annual FY2024 figure was $121.3 million, 40.68% up from the prior year.
  • Accumulated Expenses for Q3 2025 was $60.9 million at GoHealth, roughly flat from $61.0 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $121.3 million in Q4 2024 and bottomed at $26.1 million in Q1 2021.
  • The 5-year median for Accumulated Expenses is $49.5 million (2024), against an average of $52.6 million.
  • The largest annual shift saw Accumulated Expenses decreased 10.79% in 2023 before it skyrocketed 114.97% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $52.8 million in 2021, then increased by 1.03% to $53.3 million in 2022, then surged by 61.72% to $86.3 million in 2023, then skyrocketed by 40.68% to $121.3 million in 2024, then tumbled by 49.8% to $60.9 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Accumulated Expenses are $60.9 million (Q3 2025), $61.0 million (Q2 2025), and $82.2 million (Q1 2025).